EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
Center for Rheumatology · Medical University of Vienna · +67 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,743
total citations
- FWCI
- 226.22
- Percentile
- 100%
- References
- 69
Citations per year
Authors
48- JSJosef S SmolenCorresponding
Center for Rheumatology, Medical University of Vienna
- RLRobert Landewé
University Medical Center, Zuyderland Medisch Centrum, Center for Rheumatology
- SASytske Anne Bergstra
Leiden University Medical Center
- AKAndreas Kerschbaumer
Center for Rheumatology, Medical University of Vienna
- ASAlexandre Sepriano
Nova Medical (United States), Universidade Nova de Lisboa
Topics & keywords
Topics
Keywords
- Medicine
- Antirheumatic drugs
- Rheumatoid arthritis
- Antirheumatic Agents
- Arthritis
- Hydroxychloroquine
- Disease
- Biological drugs
No related works found for this paper.